Details for New Drug Application (NDA): 062372
✉ Email this page to a colleague
NDA 062372 describes MEZLIN, which is a drug marketed by Bayer Pharms and is included in four NDAs. Additional details are available on the MEZLIN profile page.
The generic ingredient in MEZLIN is mezlocillin sodium monohydrate. Additional details are available on the mezlocillin sodium monohydrate profile page.
The generic ingredient in MEZLIN is mezlocillin sodium monohydrate. Additional details are available on the mezlocillin sodium monohydrate profile page.
Summary for 062372
| Tradename: | MEZLIN |
| Applicant: | Bayer Pharms |
| Ingredient: | mezlocillin sodium monohydrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062372
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | May 13, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 3GM BASE/VIAL | ||||
| Approval Date: | May 13, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4GM BASE/VIAL | ||||
| Approval Date: | May 13, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
